Tamsulosin Hydrochloride Capsule
Product Images NDC 62756-160
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 62756-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2a (Tamsulosin Fig2a)
Figure-2b (Tamsulosin Fig2b)
Tamsulosin-fig3a (Tamsulosin Fig3a)
Tamsulosin-fig3b (Tamsulosin Fig3b)
This is a description of a medical treatment consisting of three treatments. The treatment involves administering 0.08mg of something, which is labelled as A. Two other treatments involve 0.4mg and a placebo. The success of the treatment is measured by measuring the flow rate (in mL/sec), with the results presented in a table. The duration of the treatment is measured in weeks.*
Tamsulosin-label (Tamsulosin Label)
This is a description of Tamsulosin Hydrochloride capsules, with a dosage of 0.4 mg. The drug should be stored at 20-25°C, with excursions permitted between 15-30°C. The accompanying prescribing information should be read, and patient information is available at https://www.sunpharma.com/usa/products. The capsules should be kept out of reach of children, and only dispensed with patient information by a pharmacist. The manufacturers are Sun Pharmaceutical Industries, with a place of manufacture in Gujarat, India. The NDC is 62756-160-81.*
Chemical-structure (Tamsulosin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.